Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jamila Joseph"'
Publikováno v:
Indian Journal of Transplantation, Vol 12, Iss 1, Pp 30-34 (2018)
Introduction: The present study compared the efficacy, safety, and immunogenicity of the biosimilar darbepoetin alfa to the reference innovator darbepoetin alfa in the treatment of anemia in chronic kidney disease (CKD) patients. Materials and Method
Externí odkaz:
https://doaj.org/article/f9afce92dae84f5c941804b33bde72d0
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 2, Pp 84-89 (2018)
Objective: The objective of this study was to compare efficacy, safety, and immunogenicity between the biosimilar adalimumab (AdaliRel) and the reference innovator product in moderate-to-severe rheumatoid arthritis (RA) patients on stable dose of met
Externí odkaz:
https://doaj.org/article/14d6112d3e084e7f884c6b89b54df4d4
Publikováno v:
Indian Journal of Transplantation, Vol 12, Iss 1, Pp 30-34 (2018)
Introduction: The present study compared the efficacy, safety, and immunogenicity of the biosimilar darbepoetin alfa to the reference innovator darbepoetin alfa in the treatment of anemia in chronic kidney disease (CKD) patients. Materials and Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f835c8de84c77e419344ad5f7dac7385
http://www.ijtonline.in/article.asp?issn=2212-0017
http://www.ijtonline.in/article.asp?issn=2212-0017
Publikováno v:
Indian journal of cancer. 54(4)
INTRODUCTION: The present study for biosimilar trastuzumab was a multicentric, randomized, two-arm parallel-group, comparative phase III study in patients with metastatic breast cancer. MATERIALS AND METHODS: Stage I of the study was conducted among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6cf97d9d79c6f00ddfe13d7aeb8887
https://pubmed.ncbi.nlm.nih.gov/30082554
https://pubmed.ncbi.nlm.nih.gov/30082554
Publikováno v:
Annals of Clinical Cardiology. 1:8
Objectives: Tenecteplase (TNK) is an established third-generation class 1A thrombolytic. The objective of the present study was to establish clinical biosimilarity of TNK biosimilar in a comparative phase III study with the reference product in the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd12b9ead970d1e1387f49d2cadc4233
https://doi.org/10.4103/accj.accj_6_18
https://doi.org/10.4103/accj.accj_6_18
Autor:
Jamila Joseph
Publikováno v:
Contemporary Clinical Trials. 29:311-313
India is getting to be known as a hot destination for executing clinical trials. It is witnessing the frenzied entry of pharma sponsor companies and contract research organizations and the movement of Indian non-healthcare groups into clinical resear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e31155fa36f7968186824da8446701
https://doi.org/10.1016/j.cct.2007.10.006
https://doi.org/10.1016/j.cct.2007.10.006